Inflammation-induced oxidative stress in breast cancer patients

Medical Oncology

Volumn 32, Issue 12, 2015, Pages 1-4

  Roque, Aline Tengan ^a   Gambeloni, Rafael Zuppardo ^a   Felitti, Simone ^a   Ribeiro, Marcelo Lima ^a,b   Santos, Juliana Carvalho ^a,b  

^a UNIVERSIDADE SÃO FRANCISCO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Breast cancer; Comet assay; DNA damage; Gene expression; Inflammation

Indexed keywords

CYCLOOXYGENASE 2; DNA; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; REACTIVE OXYGEN METABOLITE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GRADING; CANCER PATIENT; CANCER TISSUE; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DAMAGE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; TISSUE SECTION; BREAST TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

BREAST NEOPLASMS; COMET ASSAY; CYTOKINES; DNA DAMAGE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84946406427     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-015-0709-5     Document Type: Article

References (20)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.20107.
2. Curado MP. Breast cancer in the world: incidence and mortality. Salud Publica Mex. 2011;53(5):372–84.
3. Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res. 2005;11(16):5678–85. doi:10.1158/1078-0432.CCR-04-2421.
4. Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst. 2010;102(9):627–37. doi:10.1093/jnci/djq101.
5. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–7. doi:10.1038/nature01322.
6. Hills SA, Diffley JF. DNA replication and oncogene-induced replicative stress. Curr Biol CB. 2014;24(10):R435–44. doi:10.1016/j.cub.2014.04.012.
7. Heirman I, Ginneberge D, Brigelius-Flohe R, Hendrickx N, Agostinis P, Brouckaert P, et al. Blocking tumor cell eicosanoid synthesis by GPx4 impedes tumor growth and malignancy. Free Radic Biol Med. 2006;40(2):285–94. doi:10.1016/j.freeradbiomed.2005.08.033.
8. Mahalingaiah PK, Singh KP. Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells. PLoS One. 2014;9(1):e87371. doi:10.1371/journal.pone.0087371.
9. Rao VS, Dyer CE, Jameel JK, Drew PJ, Greenman J. Potential prognostic and therapeutic roles for cytokines in breast cancer (Review). Oncol Rep. 2006;15(1):179–85.
10. Basu S, Nachat-Kappes R, Caldefie-Chezet F, Vasson MP. Eicosanoids and adipokines in breast cancer: from molecular mechanisms to clinical considerations. Antioxid Redox Signal. 2013;18(3):323–60. doi:10.1089/ars.2011.4408.
11. Madeddu C, Gramignano G, Floris C, Murenu G, Sollai G, Maccio A. Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer. J Cell Mol Med. 2014;18(12):2519–29. doi:10.1111/jcmm.12413.
12. Leppkes M, Roulis M, Neurath MF, Kollias G, Becker C. Pleiotropic functions of TNF-alpha in the regulation of the intestinal epithelial response to inflammation. Int Immunol. 2014;26(9):509–15. doi:10.1093/intimm/dxu051.
13. Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T, et al. Inflammatory mediators in breast cancer: coordinated expression of TNFalpha & IL-1beta with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer. 2011;11:130. doi:10.1186/1471-2407-11-130.
14. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48(6):749–62. doi:10.1016/j.freeradbiomed.2009.12.022.
15. Sosa V, Moline T, Somoza R, Paciucci R, Kondoh H. ME LL. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013;12(1):376–90. doi:10.1016/j.arr.2012.10.004.
16. Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, Ramirez-Tortosa CL, Granados-Principal S, Lorente JA, et al. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Crit Rev Oncol Hematol. 2011;80(3):347–68. doi:10.1016/j.critrevonc.2011.01.004.
17. Nourazarian AR, Kangari P, Salmaninejad A. Roles of oxidative stress in the development and progression of breast cancer. Asian Pac J Cancer Prev. 2014;15(12):4745–51.
18. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer. 2000;89(12):2637–45.
19. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9(5):361–71. doi:10.1038/nrc2628.
20. Kamel M, Shouman S, El-Merzebany M, Kilic G, Veenstra T, Saeed M, et al. Effect of tumour necrosis factor-alpha on estrogen metabolic pathways in breast cancer cells. J Cancer. 2012;3:310–21. doi:10.7150/jca.4584.